Latin Manharlal Chat
BSE Prices delayed by 5 minutes...
     Prices as on May 18, 2021 - 11:16AM     
  ABB India 1456.35 [ 2.69% ]
  ACC 1918.55 [ 0.75% ]
  Axis Bank Ltd. 724.9 [ 2.21% ]
  Bank of Baroda 78.25 [ 1.43% ]
  Bharti Airtel 542.8 [ -1.23% ]
  Bharat Heavy Ele 72.1 [ 1.26% ]
  Britannia Ind. 3512.3 [ 0.19% ]
  Cipla 882.4 [ 0.15% ]
  Coal India 147.7 [ -0.37% ]
  Colgate Palm. 1579 [ -1.07% ]
  Dabur India 534.25 [ 0.14% ]
  DLF Ltd. 263.4 [ 1.60% ]
  Grasim Inds. 1393.75 [ 0.01% ]
  HCL Technologies 935 [ 1.42% ]
  HDFC 2504.35 [ 0.74% ]
  HDFC Bank 1477.7 [ 2.62% ]
  Hero MotoCorp 2904.2 [ 1.75% ]
  Hindalco Indus. 405.6 [ 3.19% ]
  ICICI Bank 633.25 [ 1.55% ]
  IDFC L 54.5 [ 1.02% ]
  IndusInd Bank 977.65 [ 2.24% ]
  Infosys 1336 [ 0.52% ]
  ITC Ltd. 212.6 [ 0.02% ]
  Jindal St & Pwr 444.6 [ 1.84% ]
  L&T 1415.6 [ 2.07% ]
  Lupin Ltd. 1186.95 [ -0.17% ]
  Mahi. & Mahi 767.65 [ 1.90% ]
  MTNL 17.85 [ -0.56% ]
  Nestle India 17127.6 [ 0.53% ]
  NIIT Ltd. 181 [ 0.42% ]
  NMDC Ltd. 192.1 [ 2.98% ]
  NTPC 113.5 [ 1.75% ]
  ONGC 114.95 [ 0.61% ]
  SBI 387.05 [ 0.95% ]
  Vedanta 284.95 [ 2.21% ]
  Sun Pharma. 692.3 [ 0.78% ]
  Tata Chemicals 716 [ 1.70% ]
  Tata Steel 1182.7 [ 2.79% ]
  Tata Power Co. 106.3 [ 2.80% ]
  Tech Mahindra 976.25 [ 2.37% ]
  United Spirits 571.3 [ 0.84% ]
  Wipro Ltd 509.25 [ 1.92% ]

Company Information

Home » Market » Company Information

Alpa Laboratories Ltd.

May 18, 11:16
54.20 -0.50 ( -0.91 %)
 
VOLUME : 7797
Prev. Close 54.70
Open Price 54.70
TODAY'S LOW / HIGH
53.55
 
 
 
56.20
Bid PRICE (QTY.) 54.20 (129)
Offer PRICE (Qty.) 55.95 (3700)
52 WK LOW / HIGH
16.80
 
 
 
73.15
May 18, 11:04
54.75 +0.65 (+ 1.20 %)
 
VOLUME : 21658
Prev. Close 54.10
Open Price 54.10
TODAY'S LOW / HIGH
53.90
 
 
 
55.90
Bid PRICE (QTY.) 54.75 (50)
Offer PRICE (Qty.) 55.40 (140)
52 WK LOW / HIGH
16.65
 
 
 
73.40
Company Information Menu

Search Company

Market Cap. ( ₹ ) 115.20 Cr. P/BV 1.15 Book Value ( ₹ ) 47.70
52 Week High/Low ( ₹ ) 73/17 FV/ML 10/1 P/E(X) 62.22
Bookclosure 29/09/2020 TTM EPS ( ₹ ) 3.30 Div Yield (%) 0.00
NOTES TO ACCOUNTS
You can view the entire text of Notes to accounts of the company for the latest year
Year End :2018-03 

Note:

(a) Held as lien by bank against bank guarantees amounting to NIL (Rs.10,00,000 as at 31 st March, 2017 and Rs. 10,00,000 as at 1 st April, 2016) and Term Loan amounting to Nil (Nil as at 31st March, 2017 and NIL as at 1 st April 2016)

(b) Includes deposits aggregating NIL (NIL as at 31st March, 2017, NIL as at 1st April, 2016) earmarked against unsecured debentures due for redemption in next twelve months.

b) Rights, preferences and restrictions attached to shares

Equity shares: The Company has one class of equity shares having a par value of Rs.10 per share. Each shareholder is eligible for one vote per share held. In the event of liquidation, the equity shareholders are eligible to receive the remaining assets of the Company after distribution of all preferential amounts, in proportion to their shareholding.

Tax effect of the amounts which are not deductible/(taxable) in calculating taxable income

Permanent Disallowances

Deduction under section 24 of the Income Tax Act

Interest income from Joint Venture on liability element of compound financial instrument

Significant Estimates : Based on the approved plans and budgets, the company has estimated that the future taxable income will be sufficient to absorb carried forward unabsorbed depreciation, which management believes is probable, accordingly the company has recognized deferred tax asset on aforesaid losses.

Note - "1"

Segment Reporting

As the Company operates in the single segment of drugs and chemicals which is the primary reportable segment as per Accounting Standard Ind As 108 on ‘Operating Segment ‘, no separate disclosure pertaining to the same has been given.

Note - "2"

Application for merger of Norfolk Mercantile Private Limited, Wholly owned subsidiary of Alpa laboratories Limited was filed before NCLT, Mumbai by Norfolk Mercantile Private Limited on 7th December, 2017.The same was approved by the Bench vide Order dated 15th December,2017.Application was also filed by Alpa laboratories Limited before NCLT Ahmedabad on 15th January, 2018.Against the application an order was issued by the Bench on 2nd February, 2018 for approval of th same in EGM by the Shareholders through Special Resolution. The EGM was conducted on 7th of May, 2018 which approved the same. The Scrutinizer report and the Chairman report was filed on 9th May, 2018. Final petition was filed before the Bench on 15th May, 2018.

BSE Limited has informed the company through letter dated 8th March, 2018 that a notice has been received by them from one of the advocates on 28th February, 2018 eluding some dispute on title of Equity Shares of Norfolk Mercantile Private Limited. Alpa Laboratories Limited will be filing requisite reply on the same.

Note - "3"

Court Case has been filed against Innovec Laboratories Private Limited ( Medicure Nagpur) for Rs.28,94,502 (Previous Year- Rs.28,94,502) for recovery of outstanding amounts.

Note - "4"

Fair Value Measurement

Financial Instrument by category and hierarchy

The fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale.

The following methods and assumptions were used to estimate the fair values:

1. Fair value of cash and short-term deposits, trade and other short term receivables, trade payables, other current liabilities, short term loans from banks and other financial institutions approximate their carrying amounts largely due to short term maturities of these instruments.

2. Financial instruments with fixed and variable interest rates are evaluated by the Company based on parameters such as interest rates and individual credit worthiness of the counterparty. Based on this evaluation, allowances are taken to account for expected losses of these receivables. Accordingly, fair value of such instruments is not materially different from their carrying amounts.

3. The fair values for loans and investment in preference shares were calculated based on cash flows discounted using a current lending rate. They are classified as level 3 fair values in the fair value hierarchy due to the inclusion of unobservable inputs including counter party credit risk.

4. The fair values of non-current borrowings are based on discounted cash flows using a current borrowing rate. They are classified as level 3 fair values in the fair value hierarchy due to the use of unobservable inputs, including own credit risk.

For financial assets and liabilities that are measured at fair value, the carriying amounts are equal to the fair values.

The Company uses the following hierarchy for determining and disclosing the fair value of financial instruments by valuation technique:

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs that have a significant effect on the recorded fair value that are not based on observable market data.

Note - "5"

Financial Risk Management

Financial risk management objectives and policies

The Company’s financial risk management is an integral part of how to plan and execute its business strategies. The Company’s financial risk management policy is set by the Managing Board.

Market risk is the risk of loss of future earnings, fair values or future cash flows that may result from a change in the price of a financial instrument. The value of a financial instrument may change as a result of changes in the interest rates, foreign currency exchange rates, equity prices and other market changes that affect market risk sensitive instruments. Market risk is attributable to all market risk sensitive financial instruments including investments and deposits, foreign currency receivables, payables and loans and borrowings.

The Company manages market risk through a treasury department, which evaluates and exercises independent control over the entire process of market risk management. The treasury department recommend risk management objectives and policies, which are approved by Senior Management and the Audit Committee. The activities of this department include management of cash resources, implementing hedging strategies for foreign currency exposures like foreign exchange forward contracts, borrowing strategies and ensuring compliance with market risk limits and policies.

Market Risk- Foreign currency risk.

The Company operates internationally and portion of the business is transacted in several currencies and consequently the Company is exposed to foreign exchange risk through its sales and services in overseas and purchases from overseas suppliers in various foreign currencies. Foreign currency exchange rate exposure is partly balanced by purchasing of goods, commodities and services in the respective currencies.

(a) (iii) Market Risk- Price Risk

(a) Exposure

The Company’s exposure to equity securities price risk arises from investments held by the Company and classified in the balance sheet either at fair value through OCI or at fair value through profit and loss. To manage its price risk arising from investments in equity securities, the Company diversifies its portfolio. Diversification of the portfolio is done in accordance with the limits set by the Company.

(b) Sensitivity

The table below summarizes the impact of increases/decreases of the BSE index on the Company’s equity and Gain/Loss for the period. The analysis is based on the assumption that the index has increased by 5 % or decreased by 5 % with all other variables held constant, and that all the Company’s equity instruments moved in line with the index.

Credit risk

Credit risk arises from the possibility that the counter party may not be able to settle their obligations as agreed. To manage this, the Company periodically assesses financial reliability of customers and other counter parties, taking into account the financial condition, current economic trends, and analysis of historical bad debts and ageing of financial assets. Individual risk limits are set and periodically reviewed on the basis of such information.

The Company considers the probability of default upon initial recognition of asset and whether there has been a significant increase in credit risk on an ongoing basis through each reporting period. To assess whether there is a significant increase in credit risk the Company compares the risk of default occurring on asset as at the reporting date with the risk of default as at the date of initial recognition. It considers reasonable and supportive forwarding-looking information such as:

i) Actual or expected significant adverse changes in business,

ii) Actual or expected significant changes in the operating results of the counterparty,

iii) Financial or economic conditions that are expected to cause a significant change to the counterparty’s ability to meet its obligations,

iv) Significant increase in credit risk on other financial instruments of the same counterparty,

v) Significant changes in the value of the collateral supporting the obligation or in the quality of the third-party guarantees or credit enhancements.

Financial assets are written off when there is no reasonable expectations of recovery, such as a debtor failing to engage in a repayment plan with the Company. Where loans or receivables have been written off, the Company continues to engage in enforcement activity to attempt to recover the receivable due. Where recoveries are made, these are recognized as income in the statement of profit and loss.

The Company measures the expected credit loss of trade receivables and loan from individual customers based on historical trend, industry practices and the business environment in which the entity operates. Loss rates are based on actual credit loss experience and past trends. Based on the historical data, loss on collection of receivable is not material hence no additional provision considered.

Liquidity Risk

Prudent liquidity risk management implies maintaining sufficient cash and marketable securities and the availability of funding through an adequate amount of committed credit facilities to meet obligations when due and to close out market positions. Due to the dynamic nature of the underlying businesses, Company treasury maintains flexibility in funding by maintaining availability under committed credit lines. Management monitors rolling forecasts of the Company’s liquidity position (comprising the undrawn borrowing facilities below) and cash and cash equivalents on the basis of expected cash flows.

Note - "6"

Capital Risk Management

a) Risk Management

The Company aim to manages its capital efficiently so as to safeguard its ability to continue as a going concern and to optimise returns to our shareholders.

The capital structure of the Company is based on management’s judgement of the appropriate balance of key elements in order to meet its strategic and day-to-day needs. We consider the amount of capital in proportion to risk and manage the capital structure in light of changes in economic conditions and the risk characteristics of the underlying assets. In order to maintain or adjust the capital structure, the Company may adjust the amount of dividends paid to shareholders, return capital to shareholders or issue new shares.

The Company’s policy is to maintain a stable and strong capital structure with a focus on total equity so as to maintain investor, creditors and market confidence and to sustain future development and growth of its business. The Company will take appropriate steps in order to maintain, or if necessary adjust, its capital structure.

Note - "7"

First-Time Adoption of Ind AS

These are the Company’s first financial statements prepared in accordance with Ind AS.

The Company has adopted Indian Accounting Standards (Ind AS) notified by the Ministry of Corporate Affairs with effect from 1 st April, 2017, with a transition date of 1st April, 2016. Ind AS 101 -First-time Adoption of Indian Accounting Standards requires that all Ind AS standards and interpretations that are issued and effective for the first Ind AS financial statements which is for the year ended 31st March, 2018 for the company, be applied retrospectively and consistently for all financial years presented. Consequently, in preparing these Ind AS financial statements, the Company has availed certain exemptions and complied with the mandatory exceptions provided in Ind AS 101, as explained below. The resulting difference in the carrying values of the assets and liabilities as at the transition date between the Ind AS and Previous GAAP have been recognised directly in equity (retained earnings or another appropriate category of equity).

Set out below are the Ind AS 101 optional exemptions availed as applicable and mandatory exceptions applied in the transition from previous GAAP to Ind AS.

A. Optional Exemptions availed

(a) Deemed Cost

The Company has opted paragraph D7 AA and accordingly considered the carrying value of property, plant and equipments and Intangible assets as deemed cost as at the transition date.

(b) Investments in subsidiaries, joint ventures and associates

The Company has opted para D14 and D15 and accordingly considered the Previous GAAP carrying amount of Investments as deemed cost as at the transition date.

B. Applicable Mandatory Exceptions

(a) Estimates

An entity’s estimates in accordance with Ind AS at the date of transition to Ind AS shall be consistent with estimates made for the same date in accordance with previous GAAP (after adjustments to reflect any difference in accounting policies).

(b) Classification and measurement of financial assets

As required under Ind AS 101 the company has assessed the classification and measurement of financial assets (investment in debt instruments) on the basis of the facts and circumstances that exist at the date of transition to Ind AS.

C. Transition to Ind AS - Reconciliations

The following reconciliations provide a quantification of the effect of significant differences arising from the transition from previous GAAP to Ind AS as required under Ind AS 101:

I. Reconciliation of Balance sheet as at April 1, 2015 (Transition Date)

II. A. Reconciliation of Balance sheet as at March 31, 2016

B. Reconciliation of Total Comprehensive Income for the year ended March 31, 2016

III. Reconciliation of Equity as at April 1, 2015 and as at March 31, 2016

IV. Adjustments to Statement of Cash Flows

The presentation requirements under Previous GAAP differs from Ind AS, and hence, Previous GAAP information has been regrouped for ease of reconciliation with Ind AS. The Regrouped Previous GAAP information is derived from the Financial Statements of the Company prepared in accordance with Previous GAAP.

A. Borrowings

As required under the IND AS 109 transactions costs incurred towards origination of borrowings have been deducted from the carrying amount of borrowings on initial recognition. These costs are recognised in the profit and loss over the tenure of the borrowing as interest expense, computed using the effective interest rate method corresponding effect being in Long term borrowings and to the extent attributable to Current maturity of long term debts.

Under the previous GAAP, these transaction costs were charged to the profit and loss as and when incurred. Consequently, borrowings as at 31st March, 2017 have been reduced by 16500 (April 1, 2016- 'Nil) with a corresponding adjustment to retained earnings resulting in increase in total equity.

B. Fair Valuation of Investments

Under the previous GAAP, investments in equity instruments and mutual funds were classified as long-term investments or current investments based on the intended holding period and realisability. Long-term investments were carried at cost less provision for other than temporary decline in the value of such investments. Current investments were carried at lower of cost and fair value. Under IND AS, these investments are required to be measured at fair value. The resulting fair value changes of these investments have been recognised in retained earnings ' 69,81,846 as at 31st March, 2017 ('2,52,14,395 As at 1 April, 2016).

C. Retained earnings

Retained earnings as at April 1, 2016 has been adjusted consequent to the above Ind AS transition adjustments.

D. Other comprehensive income

Under Ind AS, all items of income and expense recognised in a period should be included in profit or loss for the period, unless a standard requires or permits otherwise. Items of income and expense that are not recognised in profit or loss but are shown in the statement of profit and loss as ‘other comprehensive income’ includes remeasurements of defined benefit plans. The concept of other comprehensive income did not exist under previous GAAP.

E. Deferred Tax

Deferred Tax on aforesaid IND AS adjustments.

F. The Ind AS adjustments are either non cash adjustments or are regrouping among the cash flows from operating, investing and financing activities. Consequently, Ind AS adoption has no impact on the net cash flow for the year ended 31st March, 2017 as compared with the previous GAAP.

Note - "8"

Norfolk Mercantile Private Limited had issued 1,010 9% compulsory convertible Debentures of Rs.1,00,000/- each to Alpa Laboratories Limited (holding company) in the earlier years. Due to shortage of liquidity, the Subsidiary company has went into the option of Merger with the holding Company to take the benefit of synergy. By virtue of this, the Board of Directors of the holding Company and the subsidiary company approved the Scheme of amalgamation in the nature of merger in the Board meeting held on 10th August,2017 and 11th August,2017 respectively. The Board of Director's looking into the benefit of synergy and considering the fact of pending petition of Merger before the NCLT have waived the interest amount on debentures to be paid by Norfolk Mercantile Private Limited to Alpa Laboratories Limited.

Note - "9"

The Financial Statements were authorised for issue by the directors on 26th May, 2018.